Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
966.3 USD | +0.29% | -0.07% | +10.02% |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Mar. 25 | Regeneron Shares Down After FDA Letter Questioning Application for Potential Lymphoma Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.02% | 104B | |
+2.56% | 108B | |
+7.86% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B | |
-5.38% | 10.36B |
- Stock
- Equities
- Stock Regeneron Pharmaceuticals, Inc. - Nasdaq
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals : Pfizer begins early-stage study of oral COVID-19 drug